Voice changes in patients with chronic obstructive pulmonary disease

Voice changes in patients with chronic obstructive pulmonary disease

Introduction: Voice changes are not a direct symptom of chronic obstructive pulmonary disease (COPD), but many COPD patients experience voice changes. Aim of the work: The aim of this work was to establish the voice changes in patients with chronic obstructive pulmonary disease. Patients and methods...

Full description

Bibliographic Details
Main Authors:	Enas Elsayed Mohamed, Riham Ali El maghraby
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-07-01
Series:	Egyptian Journal of Chest Disease and Tuberculosis
Subjects:	Chronic obstructive pulmonary disease Dysphonia Smoking Inhaled corticosteroids
Online Access:	http://www.sciencedirect.com/science/article/pii/S0422763814000685

Similar Items

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01)

Pharmacological therapy for stable chronic obstructive pulmonary disease
by: Ruirui Duan, et al.
Published: (2023-06-01)

Use of Inhaled Corticosteroids and Risk of Acquiring <i>Haemophilus influenzae</i> in Patients with Chronic Obstructive Pulmonary Disease
by: Raza Ul Mohsin, et al.
Published: (2022-06-01)

Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study
by: Lee JH, et al.
Published: (2020-12-01)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01)

A Prediction Scoring Model for the Effect of Withdrawal or Addition of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease
by: Lee JH, et al.
Published: (2023-02-01)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
by: Pradeesh Sivapalan, et al.
Published: (2021-02-01)

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History
by: Andrea S. Melani, et al.
Published: (2024-02-01)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
by: Marc Miravitlles, et al.
Published: (2017-11-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
by: G.I. Butel-Simoes, et al.
Published: (2023-12-01)

Laryngeal candidiasis due to inhaled corticosteroid: a case report
by: Utku Kubilay, et al.
Published: (2005-12-01)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
by: Yong Suk Jo, M.D., et al.
Published: (2020-01-01)

Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2022-07-01)

Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2023-06-01)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
by: Choi JH, et al.
Published: (2021-11-01)

National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-02-01)

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
by: Hsieh MJ, et al.
Published: (2018-09-01)

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
by: Nicolas Migueres, et al.
Published: (2022-12-01)

Blood eosinophil count in patients with COPD on inhaled corticosteroids in comparison with healthy smoker and nonsmoker controls
by: Noha Othman Ahmed, et al.
Published: (2021-01-01)

An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients
by: Rahul Sharma, et al.
Published: (2021-01-01)

Evaluation of inhaler use technique among patients with chronic obstructive pulmonary disease
by: Asieh Hatefi, et al.
Published: (2021-06-01)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
by: Liu SF, et al.
Published: (2016-07-01)

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
by: Wang CY, et al.
Published: (2016-11-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Triple therapy in a single inhaler for chronic obstructive pulmonary disease: clinical studies and case report (real practice)
by: V. V. Salukhov, et al.
Published: (2021-10-01)

Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
by: Magdalena Humenberger, et al.
Published: (2018-10-01)

Newer therapeutic options in chronic obstructive pulmonary disease
by: Jesin Kumar Chakkamadathil
Published: (2023-01-01)

The influence of oxygenotherapy on the hypercapnia in patients with chronic obstructive pulmonary disease
by: Lazić Zorica, et al.
Published: (2008-01-01)

Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
by: Shahideh Amini, PharmD, et al.
Published: (2020-01-01)

Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease
by: Bang C, et al.
Published: (2013-09-01)

Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care
by: Annika Lindh, et al.
Published: (2019-10-01)

Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil–to–lymphocyte ratio, and mortality outcomes in US adults
by: Han-Shuo Hu, et al.
Published: (2023-11-01)

Acute exacerbation of chronic obstructive pulmonary disease in rural area: Why, how, and what next?
by: Ravish M Kshatriya, et al.
Published: (2019-01-01)

Preoperative inhalation therapy for patients with chronic obstructive pulmonary disease undergoing lung surgery: a retrospective study
by: Ryusuke Machino, et al.
Published: (2022-11-01)

Cognitive impairment and its effect on chronic obstructive pulmonary disease: An underestimated phenomenon
by: Sachin L Patel, et al.
Published: (2020-01-01)

The Incidence and Risk Analysis of Lung Cancer Development in Patients with Chronic Obstructive Pulmonary Disease: Possible Effectiveness of Annual CT-Screening
by: Machida H, et al.
Published: (2021-03-01)

Public health interventions to minimize the impact of chronic obstructive pulmonary disease
by: Saurabh RamBihariLal Shrivastava, et al.
Published: (2022-01-01)

Inhaler use in chronic obstructive pulmonary disease patients: a meta-analysis†
by: Zhou Li-Juan, et al.
Published: (2022-12-01)

An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
by: Seçil Çakmaklı, M.D., et al.
Published: (2023-08-01)